![]() |
Neoplasms of the CNS |
Free Subscription
2 Acta Neuropathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Neoplasms of the CNS is free of charge.
Prospective characterization of germline variants in patients with gliomas and
glioneuronal tumors.
Acta Neuropathol. 2025;150:27.
PubMed
Abstract available
Pineal region high-grade neuroepithelial tumors with NTRK fusions map to the
novel methylation class "diffuse high-grade glioma, IDH-wild type, subtype E".
Acta Neuropathol. 2025;150:26.
PubMed
Meta-analysis evaluating the efficacy and safety of various Bruton tyrosine
kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK
inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment
of primary ce
Cancer. 2025;131:e70083.
PubMed
Abstract available
Determinants of geographic variation in the incidence of adult nonmalignant
meningioma in the United States, 2010-2019.
Cancer. 2025;131:e70042.
PubMed
Abstract available
Opposite patterns of association of TWIST1 expression with patient survival in
SHH and Group 4 medulloblastoma.
Childs Nerv Syst. 2025;41:277.
PubMed
Abstract available
Intradiploic meningioma with spontaneous epidural hematoma in a child: a case
report.
Childs Nerv Syst. 2025;41:278.
PubMed
Abstract available
Shared decision-making interventions in neuro-oncology practice: a systematic
review.
J Neurooncol. 2025;175:471-479.
PubMed
Abstract available
Prognostic factors for local failure and overall survival in patients with
epidural disease at the cauda equina following stereotactic body radiotherapy: a
clinical, anatomic and dosimetric analysis.
J Neurooncol. 2025;175:621-631.
PubMed
Abstract available
Enhancing the therapeutic effect on tumor cells through wireless optoelectronic
stimulation.
J Neurooncol. 2025;175:741-752.
PubMed
Abstract available
Stereotactic radiosurgery for intracranial and spinal adenoid cystic carcinoma:
systematic review and illustrative case presentation.
J Neurooncol. 2025;175:493-505.
PubMed
Abstract available
Intrathecal pemetrexed for newly diagnosed leptomeningeal metastases: a
multicenter, open-label, phase I/II study.
J Neurooncol. 2025;175:857-868.
PubMed
Abstract available
Clinical and neuropathological criteria for distinguishing between IDH-mutant
astrocytomas of WHO grade 2 and 3.
J Neurooncol. 2025;175:763-774.
PubMed
Abstract available
Global burden of brain and central nervous system cancer in 185 countries, and
projections up to 2050: a population-based systematic analysis of GLOBOCAN 2022.
J Neurooncol. 2025;175:673-685.
PubMed
Abstract available
Clinical and genomic factors differ in pediatric and adult pilocytic astrocytoma:
a single-center experience with over 350 patients.
J Neurooncol. 2025;175:539-547.
PubMed
Abstract available
Repeat stereotactic radiosurgery for treatment of brain metastases locally
recurrent following initial radiosurgery.
J Neurooncol. 2025 Sep 7. doi: 10.1007/s11060-025-05201.
PubMed
Abstract available
NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive
meningiomas.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05208.
PubMed
Abstract available
Impact of substructure radiation dose on health-related quality of life in
children with brain tumors: a Pediatric Proton/Photon Consortium Registry (PPCR)
study.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05211.
PubMed
Abstract available
Role of patient frailty in resection of newly diagnosed motor eloquent
glioblastomas guided by a navigated transcranial magnetic stimulation and
tractography approach.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05206.
PubMed
Abstract available
Prognostic value of hypertension timing for survival in glioblastoma patients
receiving bevacizumab: a retrospective single centre analysis.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05209.
PubMed
Abstract available
Microvessel density as a prognostic and predictive biomarker in newly diagnosed
glioblastoma: correlations with radiological features and bevacizumab efficacy.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05210.
PubMed
Abstract available
Clinical-pathological patterns and prognosis of young women with breast cancer
brain metastases: a single-center retrospective study.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05212.
PubMed
Abstract available
Photodynamic therapy for glioblastoma: a narrative review.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05217.
PubMed
Abstract available
Correction to: PIK3R2 immunostaining status predicts prognosis in patients with
newly diagnosed glioblastoma treated with an autologous tumor vaccine.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05203.
PubMed
Utility and performance of cerebrospinal fluid cytology in discriminating central
nervous system infections and brain tumors.
J Neurooncol. 2025 Sep 10. doi: 10.1007/s11060-025-05214.
PubMed
Abstract available
Physician-led versus questionnaire-based psychosocial screening in adults with
high-grade glioma: a cluster-randomized controlled trial (GLIOPT).
J Neurooncol. 2025 Sep 10. doi: 10.1007/s11060-025-05223.
PubMed
Abstract available
Unveiling regional differences in glioblastoma patient survival with real-world
data from the Norwegian brain tumor quality registry.
J Neurooncol. 2025 Sep 11. doi: 10.1007/s11060-025-05218.
PubMed
Abstract available
Functional status in long-term survivors after mapping-guided surgery for diffuse
low-grade glioma: a consecutive series of 103 patients with a postoperative
follow-up of at least 15 years.
J Neurosurg. 2025 Sep 12:1-12. doi: 10.3171/2025.5.JNS25819.
PubMed
Abstract available
Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT
and Histopathology in Patients with Suspected Intracranial Meningiomas.
J Nucl Med. 2025 Sep 11:jnumed.125.270115. doi: 10.2967/jnumed.125.270115.
PubMed
Abstract available
FOXR2 activation is not exclusive of CNS neuroblastoma.
Neuro Oncol. 2025;27:1801-1812.
PubMed
Abstract available
Do we need B7-H3 immunohistochemistry for the inclusion of children with
high-grade central nervous system tumors in clinical trials targeting B7-H3?
Neuro Oncol. 2025;27:1864-1877.
PubMed
Abstract available
Postoperative fluid restriction to prevent delayed hyponatremia after endoscopic
transsphenoidal surgery.
Neuro Oncol. 2025;27:1746-1757.
PubMed
Abstract available
High-throughput in vitro drug screening and in vivo studies identify fenretinide
as a brain-penetrant DMG therapeutic.
Neuro Oncol. 2025;27:1813-1828.
PubMed
Abstract available
Preoperative embolization improves local control and modulates gene expression in
atypical WHO grade 2 meningioma.
Neuro Oncol. 2025 Sep 2:noaf203. doi: 10.1093.
PubMed
Abstract available
Window of opportunity evaluation of blood-brain barrier permeability
heterogeneity within and across high-grade glioma patients.
Neuro Oncol. 2025 Sep 6:noaf204. doi: 10.1093.
PubMed
Abstract available
Integrated single-cell and spatial transcriptomics uncover the prognostic,
epigenetic, and immunological roles of FANCC in low-grade glioma.
Neurol Res. 2025 Sep 9:1-17. doi: 10.1080/01616412.2025.2556255.
PubMed
Abstract available
Predicting molecular subtypes of pediatric medulloblastoma using MRI-based
artificial intelligence: A systematic review and meta-analysis.
Neuroradiology. 2025 Sep 12. doi: 10.1007/s00234-025-03759.
PubMed
Abstract available
High-Resolution Mapping of Tumor and Peritumoral Glutamate and Glutamine in
Gliomas Using 7-T MRSI.
Radiol Imaging Cancer. 2025;7:e240494.
PubMed
Abstract available
Thank you for your interest in scientific medicine.